These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4403852)

  • 1. The effect of chlorpromazine on drug metabolism.
    Stevenson IH; O'Malley K; Turnbull MJ; Ballinger BR
    J Pharm Pharmacol; 1972 Jul; 24(7):577-8. PubMed ID: 4403852
    [No Abstract]   [Full Text] [Related]  

  • 2. Spironolactone--a weak enzyme inducer in man.
    Taylor SA; Rawlins MD; Smith SE
    J Pharm Pharmacol; 1972 Jul; 24(7):578-9. PubMed ID: 4403853
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative enzyme-inducing effects of chlorpromazine and fluphenazine therapies in psychotic patients.
    Harman AW; Frewin DB; Priestly BG
    Psychopharmacology (Berl); 1980; 69(1):35-7. PubMed ID: 6771823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of drug pretreatment on antipyrine levels in blood and tissues: an example of multiple drug interactions.
    Sotaniemi EA
    Pharmacology; 1973; 10(5):306-16. PubMed ID: 4764537
    [No Abstract]   [Full Text] [Related]  

  • 5. Abnormal drug metabolism after barbiturate and paracetamol overdose.
    Forrest JA; Roscoe P; Prescott LF; Stevenson IH
    Br Med J; 1974 Nov; 4(5943):499-502. PubMed ID: 4434117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired enzyme induction by rifampicin in the elderly.
    Twum-Barima Y; Finnigan T; Habash AI; Cape RD; Carruthers SG
    Br J Clin Pharmacol; 1984 May; 17(5):595-7. PubMed ID: 6733008
    [No Abstract]   [Full Text] [Related]  

  • 7. Gross impairment of hepatic drug metabolism in a patient with chronic liver disease.
    Adjepon-Yamoah KK; Nimmo J; Prescott LF
    Br Med J; 1974 Nov; 4(5941):387-8. PubMed ID: 4425889
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in D-glucaric acid excretion in relationship to alterations in the rate of antipyrine metabolism in man.
    Hunter J; Burnham WR; Chasseaud LF; Down W
    Biochem Pharmacol; 1974 Sep; 23(17):2480-3. PubMed ID: 4429583
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of labetalol on antipyrine metabolism in the liver].
    Adamska-Dyniewska H; Dziekański S
    Pol Arch Med Wewn; 1984 Mar; 71(3):149-55. PubMed ID: 6739318
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of six beta-adrenolytics and labetalol on hepatic biotransformation studied by antipyrine test, in man.
    Adamska-Dyniewska H; Dziekański S; Pruszczyński J
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):303-7. PubMed ID: 2874117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced drug metabolism in cigarette smokers.
    Hart P; Farrell GC; Cooksley WG; Powell LW
    Br Med J; 1976 Jul; 2(6028):147-9. PubMed ID: 1276835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal drug metabolism following barbiturate and paracetamol overdosage.
    Forrest AH; Roscoe P; Stevenson IH; Prescott LF
    Scott Med J; 1974 May; 19(3):157. PubMed ID: 4829646
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduced induction of drug metabolism in the elderly.
    Salem SA; Rajjayabun P; Shepherd AM; Stevenson IH
    Age Ageing; 1978 May; 7(2):68-73. PubMed ID: 665427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of orphenadrine and phenobarbitone with chlorpromazine: plasma concentrations and effects in man.
    Loga S; Curry S; Lader M
    Br J Clin Pharmacol; 1975 Jun; 2(3):197-208. PubMed ID: 791320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired oxidation of antipyrine in stagnant loop rats.
    Aarbakke J
    Scand J Gastroenterol; 1977; 12(8):929-35. PubMed ID: 605352
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of flurbiprofen on the metabolism of antipyrine in man.
    Chalmers IM; Bell MA; Buchanan WW
    Ann Rheum Dis; 1973 Jan; 32(1):58-61. PubMed ID: 4539857
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of microsomal drug metabolism by 2-((2-(4-pyridyl)-methyl)-thio)-benzimidazole (H-718).
    Varga F; Fischer E; Szily T
    Acta Physiol Acad Sci Hung; 1973; 44(3-4):227-34. PubMed ID: 4807135
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative investigation of antipyrine half-life and induction of cytochrome P-450 dependent monooxygenases in rats treated with phenylurea herbicides.
    Schoket B; Zilahy Z; Molnar J; Vincze I
    In Vivo; 1987; 1(3):185-7. PubMed ID: 2979785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered elimination of antipyrine in patients with acute viral hepatitis.
    Burnett DA; Barak AJ; Tuma DJ; Sorrell MF
    Gut; 1976 May; 17(5):341-4. PubMed ID: 1278717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interindividual differences in rates of drug oxidation in man.
    Davies DS; Thorgeirsson SS; Breckenridge A; Orme M
    Drug Metab Dispos; 1973; 1(1):411-7. PubMed ID: 4149412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.